Asterias Biotherapeutics Inc. Common Series A (AST) Declined -8.65% or -0.09 To Price $0.95 On Friday


Asterias Biotherapeutics Inc. Common Series A (AST) declined -8.65% or -0.09 to $0.95. It is near to 96317 shares traded, which is 37.4% compare to the average total volume 257564. The market cap of AST is $52.88 million. The year to date change is 31.05%. The 52 week price range is from $0.51 to $2.3. Price of AST have changed 50.72% during last week. It have changed 67.74% over last month, 1.96% over last 3 months, -35.00% over last 6 months and -52.73% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for AST is 0.88. It is -7.37% below current price. The 200-day Moving Averages for AST is 1.31. It is 37.89% above current price. The 52-week High is 2.3. It is 142.11% from the current price. The 52-week Low is 0.51. It is -46.32% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of AST is 1.55 on 2019-01-15. Short % to float is 0.67%. There are some statistics of AST. It is has market cap $52.88 million. The share outstanding is 55.66 million. The average volume is 257564. The percent of top 15 Institution holding is 17.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of AST is -72.60%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of AST is -55.84%.


Tags:

Share this post